Guselkumab

Guselkumab
Monoclonal antibody
Type	Whole antibody
Source	Human
Target	IL23
Clinical data
Pronunciation	/ɡjuˈsɛlkjumæb/; gew-SEL-kew-mab
Trade names	Tremfya
AHFS/Drugs.com	Monograph
MedlinePlus	a617036
License data	US DailyMed: Guselkumab;
Pregnancy; category	AU: B1;
Routes of; administration	Subcutaneous
ATC code	L04AC16 (WHO) ;
Legal status
Legal status	AU: S4 (Prescription only); CA: Rx-only, Schedule D; UK: POM (Prescription only); US: ℞-only; EU: Rx-only;
Identifiers
CAS Number	1350289-85-8;
DrugBank	DB11834;
ChemSpider	none;
UNII	089658A12D;
KEGG	D10438;
Chemical and physical data
Formula	C6402H9864N1676O1994S42
Molar mass	143561.59 g·mol−1

Guselkumab, sold under the brand name Tremfya, is a monoclonal antibody against interleukin-23 used for the treatment of plaque psoriasis, psoriatic arthritis, and ulcerative colitis.